Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 5, 1999, Pages 268-274

  Adamcová, Michaela ^a   Geršl, Vladimír ^c   Hrdina, Radomír ^c   Mělka, Milan ^c   Mazurová, Yvøena ^c   Vávrová, Jaroslava ^b   Palička, Vladimír ^b   Kokštein, Zdeněk ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c NONE

Author keywords

Cardiac troponin T; Cardiomyopathy; Daunorubicin; Oracin; Rabbits

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DAUNORUBICIN; ORACIN; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CAUSE OF DEATH; CONTROLLED STUDY; HEART MUSCLE INJURY; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; DAUNORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETHANOLAMINES; INFUSIONS, INTRAVENOUS; ISOQUINOLINES; MALE; MYOCARDIUM; RABBITS; TROPONIN T;

EID: 0032977091     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050273     Document Type: Article

References (39)

1. Adamcová M, Kokštein Z, Vávrová J (1997) Clinical utility of cardiac troponin I and cardiac troponin T measurements. Acta Med 40:83-87
2. Adamcová M, Geršl V, Hrdina R, Palička V, Mazurová Y (1999) Contribution to prediction and pathogenesis of daunorubicininduced cardiomyopathy in rabbits. Exp Clin Cardiol (in press)
3. Adams JE, Dávila-Román VG, Bessey PQ, Blake PD, Ladenson JH, Jaffe AS (1996) Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 131:308-312
4. Bristow MR, Mason JW, Billingham ME, Daniels JR (1978) Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62:873-879
5. Ewer MS, Khalil A, Mackay B (1984) A comparison of cardiac biopsy grades and ejection fraction estimations receiving adriamycin. J Clin Oncol 2:112-117
6. Ferrans VJ (1978) Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat Rep 62:955-961
7. Fink FM, Gense N, Fink Ch, Falk M, Mair J (1995) Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy. Med Pediatr Oncol 25:185-189
8. Gerhardt W, Katus HA, Ravkilde J, Hamm C, Jorgensen PJ, Peheim E, Ljungdahl L, Lofdahl P (1991) S-troponin T in suspected ischaemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 37:1405-1411
9. Geršl V (1994) Oracin (project no. 31066) Final research report. Faculty of Medicine, Charles University, Hradec Králové, pp 1-48
10. Geršl V, Hrdina R (1994) Noninvasive polygraphic changes in daunorubicin-induced cardiomyopathy in rabbits. Sb Věd Pr Lek Fak Univ Karlovy v Hradci Králové 37:49-55
11. Geršl V, Mazurová Y, Bajgar J, Mělka M, Hrdina R, Palička V (1996) Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivative of indenoisochinoline: comparison with daunorubicin in rabbits. Arch Toxicol 70:645-651
12. Goebel M, Kaplan E (1992) Anthracycline-induced cardiotoxicity. Oncology 15:198-204
13. Hamm CW, Ravkilde J, Gerhardt W (1992) The prognostic value of serum troponin T in unstable angina. N Engl J Med 327:146-150
14. Herman HE, Lipshultz SE, Rifai N, Zhang J, Papoian T, Yu ZX, Ferrans VJ (1996) Cardiac troponin T: elevated serum levels and loss from cardiac myocytes in doxorubicin toxicity. Circulation 94:I-85
15. Katus HA, Kubler W (1990) Detection of myocardial cell damage in patients with unstable angina by serodiagnostic tools. In: Bleifeld W, Hamm CW, Braunwald E (eds) Unstable angina. Springer verlag, Berlin Heidelberg New York, pp 92-102
16. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KH, Kubler W (1991a) Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902-912
17. Katus HA, Rempis A, Scheffold T, Diederich KH, Kubler W (1991b) Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 67:1360-1367
18. Kreuser ED, Voller H, Behles Ch (1993) Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgin's disease. Bri J Hematol 84:615-622
19. Lang K, Sigushi HH, Borner A, Hoffmann, Kuhnert H, Leder U, Muller S (1996) Minimal myocardial lesions caused by endomyocardial biopsy can be detected by a commercially available cardiac troponin T enzyme-linked immunosorbent assay. Eur J Clin Invest 26:451-453
20. Lipshultz SE, Colan SD (1993) The use of echocardiography and Holter monitoring in assesment of anthracycline-treated patients. In: Bricker JT, et al (eds) Cardiac toxicity after treatment for childhood cancer. Wiley-Liss, New York, pp 45-62
21. Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, Ottlinger ME (1997) Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 96:2641-2648
22. Mair J (1997) Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci 34:1-66
23. Mělka M (1993) (ed) Oracin, Preclinical study (in Czech), VUFB, Praha, pp 1-461
24. Mesnard L, Samson F, Espinasse I, Durand J, Neveux JY, Mercadier JJ (1993) Molecular cloning and developmental expression of human cardiac troponin T. FEBS Lett 328:139-144
25. Missov E, Pau B, Calzolari C (1996) Increased circulating levels of cardiac troponin I in anthracycline-treated patients. Circulation 94:I-732
26. Missov E, Calzolari C, Pau B (1997) Increased levels of cardiac troponin I in cancer patients. J Am Coll Cardiol 129:321a
27. O'Brien PJ, Dameron GW, Beck ML, Kang YJ, Erickson BK, Di Battista TH, Miller KE, Jackson KN, Mittelstadt S (1997) Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci 47:486-495
28. Praga C, Beretta G, Vigo PL, Lenaz GR, Pollini C, Bonadonna G, Canetta R, Castellani R, Villa E, Gallagher CG, von Melchner H, Hayat M, Ribaud P, De Wasch G, Mattsson W, Heinz R, Waldner R, Kolarik K, Buehner R, Bokkel-Huyninck WT, Perevodchikova NI, Manziuk LA, Senn HJ, Mayr AC (1979) Adriamycin cardiotoxicity: a survey of 1273 patients. Cancer Treat Rep 63:5
29. Raderer M, Kornek G, Weinlander G, Kastner J (1997) Serum troponin T levels in adults undergoing anthracycline therapy. J Natl Cancer Inst 89:179
30. Seino Y, Tomita Y, Nagae Y, Kusama Y, Hirokazu H, Sasaki T, Horii I (1993) Cardioprotective effects of ACE-inhibitor (Cilazapril) on Adriamycin cardiotoxicity in spontaneously hypertensive rats. Circulation 88:I-633
31. Sinha BK (1982) Myocardial toxicity of anthracyclines and other antitumour agents. In: Van Stee EW (ed) Cardiovascular toxicology. Raven, New York
32. Sperber AD, Cantor AA, Biran H, Keynan A (1987) Selective right ventricular dysfunction following doxorubicin therapy Isr J Med Sci 23:896-899
33. Steinherz LJ, Graham T, Hurwitz R (1992) Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the cardiology committee of the childrens cancer study group. Pediatrics 89:942-948
34. Stoddard MF, Seeger J, Liddell NE (1992) Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 20:62-69
35. Unverferth BJ, Magorien RD, Balcerzak SP, Leier CV, Unverferth DV (1983) Early changes in human myocardial nuclei after doxorubicin. Cancer 52:215-221
36. Weissler AM, Harris WS, Schoenfeld CD (1969) Bedside technique for evaluation of ventricular function in man. Am J Cardiol 23:577-583
37. Woolf N (1992) Ischemia and infarction. In: McGee JO'D, Isaacson PG, Wright NA (eds) Oxford textbook of pathology, vol 1. Oxford University Press, Oxford New York Tokyo, pp 525-530
38. Wu AHB, Lane PL (1995) Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem 41:1228-1233
39. Yamashita J, Ogawa M, Shirakusa T (1995) Plasma endothelin-1 as a marker for doxorubicin cardiotoxicity. Int J Cancer 62:542-547